Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

Exclusion Criteria

• •Unwilling to discontinue current AD medications prior to the study or require treatment with prohibited medications during the study
• •Prior treatment with JAK inhibitors
• •Other active nonAD inflammatory skin diseases or conditions affecting skin
• •Medical history including thrombocytopenia, coagulopathy or platelet dysfunction, Q wave interval abnormalities, current or history of certain infections, cancer, lymphoproliferative disorders and other medical conditions at the discretion of the investigator
• •Pregnant or breastfeeding women, or women of childbearing potential who are unwilling to use contraception